Beverly Sha to Male
This is a "connection" page, showing publications Beverly Sha has written about Male.
Connection Strength
0.420
-
Evolution of an Electronic Health Record Based-Human Immunodeficiency Virus (HIV) Screening Program in an Urban Emergency Department for Diagnosing Acute and Chronic HIV Infection. J Emerg Med. 2019 11; 57(5):732-739.
Score: 0.054
-
Enhanced inpatient rounds, appointment reminders, and patient education improved HIV care engagement following hospital discharge. Int J STD AIDS. 2018 06; 29(7):641-649.
Score: 0.048
-
Kikuchi-Fujimoto disease: hydroxychloroquine as a treatment. Clin Infect Dis. 2004 Dec 15; 39(12):e124-6.
Score: 0.019
-
Lack of association between dyslipidemia and insulin resistance in HIV-infected persons treated with highly active antiretroviral therapy. Nutrition. 2004 Nov-Dec; 20(11-12):1022-5.
Score: 0.019
-
Safety and immunogenicity of a polyvalent peptide C4-V3 HIV vaccine in conjunction with IL-12. AIDS. 2004 May 21; 18(8):1203-6.
Score: 0.019
-
Development of a predictive model for identifying women vulnerable to HIV in Chicago. BMC Womens Health. 2023 Jun 16; 23(1):313.
Score: 0.017
-
Cytomegalovirus Immunoglobulin G (IgG) Titer and Coronary Artery Disease in People With Human Immunodeficiency Virus (HIV). Clin Infect Dis. 2023 02 08; 76(3):e613-e621.
Score: 0.017
-
A pilot study of the safety and efficacy of supplemental arginine to enhance immune function in persons with HIV/AIDS. Nutrition. 2002 Jul-Aug; 18(7-8):688-90.
Score: 0.016
-
Canonical Wnts Mediate CD8+ T Cell Noncytolytic Anti-HIV-1 Activity and Correlate with HIV-1 Clinical Status. J Immunol. 2020 10 15; 205(8):2046-2055.
Score: 0.014
-
Efficacy and safety of the combination of efavirenz and abacavir in HIV-infected patients failing antiretroviral therapy. AIDS. 2000 Jul 07; 14(10):1470-1.
Score: 0.014
-
Absence of virological changes after acute febrile illnesses in two patients with undetectable pre-illness plasma HIV-1-RNA levels. AIDS. 2000 Apr 14; 14(6):746-8.
Score: 0.014
-
Implementing Rapid Initiation of Antiretroviral Therapy for Acute HIV Infection Within a Routine Testing and Linkage to Care Program in Chicago. J Int Assoc Provid AIDS Care. 2020 Jan-Dec; 19:2325958220939754.
Score: 0.014
-
Dolutegravir plus lamivudine for initial treatment of HIV-1-infected participants with HIV-1 RNA <500?000 copies/mL: week 48 outcomes from ACTG 5353. J Antimicrob Chemother. 2019 05 01; 74(5):1376-1380.
Score: 0.013
-
ACTG A5353: A Pilot Study of Dolutegravir Plus Lamivudine for Initial Treatment of Human Immunodeficiency Virus-1 (HIV-1)-infected Participants With HIV-1 RNA <500000 Copies/mL. Clin Infect Dis. 2018 05 17; 66(11):1689-1697.
Score: 0.012
-
Acute HIV Discovered During Routine HIV Screening With HIV Antigen-Antibody Combination Tests in 9 US Emergency Departments. Ann Emerg Med. 2018 07; 72(1):29-40.e2.
Score: 0.012
-
Use of posaconazole delayed-release tablets for treatment of invasive aspergillosis. Mycoses. 2015 May; 58(5):313-4.
Score: 0.010
-
False-positive HIV test: implications for the patient. JAMA. 1993 Jun 09; 269(22):2847.
Score: 0.009
-
Pneumocystis carinii choroiditis in patients with AIDS: clinical features, response to therapy, and outcome. J Acquir Immune Defic Syndr (1988). 1992 Oct; 5(10):1051-8.
Score: 0.008
-
Prevalence of measles antibodies in asymptomatic human immunodeficiency virus-infected adults. J Infect Dis. 1991 Nov; 164(5):973-5.
Score: 0.008
-
Suppression of cytomegalovirus retinitis in persons with AIDS with high-dose intravenous acyclovir. J Infect Dis. 1991 Oct; 164(4):777-80.
Score: 0.008
-
Development of histoplasmosis in a human immunodeficiency virus-infected patient receiving fluconazole. J Infect Dis. 1991 Sep; 164(3):622-3.
Score: 0.008
-
Policosanol for managing human immunodeficiency virus-related dyslipidemia in a medically underserved population: a randomized, controlled clinical trial. Altern Ther Health Med. 2011 Mar-Apr; 17(2):30-5.
Score: 0.007
-
Classic pyomyositis of the extremities as an unusual manifestation of Blastomyces dermatitidis: a report of two cases. Mycoses. 2010 Jul; 53(4):356-9.
Score: 0.007
-
Coronary artery calcification on electron beam computed tomography: a 6-year follow-up study of HIV-infected patients. J Acquir Immune Defic Syndr. 2008 Sep 01; 49(1):113-4.
Score: 0.006
-
Safety, tolerability, pharmacokinetics, and efficacy of an interleukin-2 agonist among HIV-infected patients receiving highly active antiretroviral therapy. J Interferon Cytokine Res. 2008 Feb; 28(2):89-100.
Score: 0.006
-
Herpes simplex virus hepatitis: expanding the spectrum of disease. Transpl Infect Dis. 2006 Sep; 8(3):171-6.
Score: 0.005
-
Serious adverse cutaneous and hepatic toxicities associated with nevirapine use by non-HIV-infected individuals. J Acquir Immune Defic Syndr. 2004 Feb 01; 35(2):120-5.
Score: 0.005
-
HIV-1-infected antiretroviral-treated patients with prolonged partial viral suppression: clinical, virologic, and immunologic course. J Acquir Immune Defic Syndr. 2003 Dec 15; 34(5):491-6.
Score: 0.005
-
Age-related immune dysfunction in health and in human immunodeficiency virus (HIV) disease: association of age and HIV infection with naive CD8+ cell depletion, reduced expression of CD28 on CD8+ cells, and reduced thymic volumes. J Infect Dis. 2003 Jun 15; 187(12):1924-33.
Score: 0.004
-
Single-center experience: tacrolimus and mycophenolate mofetil in early stage of kidney transplantation with liver dysfunction. Transplant Proc. 2003 Feb; 35(1):273-4.
Score: 0.004
-
A pilot study of the safety and efficacy of cholestin in treating HIV-related dyslipidemia. Nutrition. 2002 Feb; 18(2):201-4.
Score: 0.004
-
Comparison of standard and immune-enhancing oral formulas in asymptomatic HIV-infected persons: a multicenter randomized controlled clinical trial. JPEN J Parenter Enteral Nutr. 2002 Jan-Feb; 26(1):6-14.
Score: 0.004
-
Thalidomide for the treatment of esophageal aphthous ulcers in patients with human immunodeficiency virus infection. National Institute of Allergy and Infectious Disease AIDS Clinical Trials Group. J Infect Dis. 1999 Jul; 180(1):61-7.
Score: 0.003
-
Incorporation of zidovudine into leukocyte DNA from HIV-1-positive adults and pregnant women, and cord blood from infants exposed in utero. AIDS. 1999 May 28; 13(8):919-25.
Score: 0.003
-
Treatment of patients with advanced HIV infection and zidovudine intolerance with dideoxyinosine. AIDS. 1992 Jul; 6(7):748-9.
Score: 0.002